Literature DB >> 27159644

A retrospective controlled study of thiol disulfide homeostasis as a novel marker in Crimean Congo hemorrhagic fever.

Zeliha Kocak Tufan1, Imran Hasanoglu1, Servet Kolgelier2, Murat Alisik3, Merve Ergin3, Gul Ruhsar Yilmaz1, Mehmet A Tasyaran1, Ozcan Erel3, Rahmet Guner1.   

Abstract

OBJECTIVES: Crimean Congo hemorrhagic fever (CCHF) is the second most common hemorrhagic fever worldwide. This study aimed to evaluate the oxidant-antioxidant balance of patients with CCHF by detecting dynamic thiol disulfide homeostasis (TDH), which is a novel oxidative stress marker, and other molecules, including paraoxonase (PON), arylesterase (ARES), ceruloplasmin (CLP), myeloperoxidase (MPO), and catalase.
METHODS: This retrospective, cross-sectional, controlled study, which involved patients with CCHF and healthy volunteers, measured dynamic TDH using a novel automated method developed by Erel.
RESULTS: We recruited 69 adult patients with CCHF (31 females, 38 males, median age 46 years). The case fatality rate was 1.49% (1/69). Increased disulfide/native thiol and disulfide/total thiol ratios, decreased total antioxidant status (TAS), and increased total oxidant status (TOS) were found in patients with CCHF. TAS, PON, and ARES values were found to be positively correlated with both native and total thiol levels, whereas TOS and CLP were negatively correlated with both, at a significant level. MPO activity was similar in both groups. DISCUSSION: This is the first study in the literature to evaluate dynamic TDH in CCHF. TDH shifts to the oxidative side in patients with CCHF, leading to an increase in TOS.

Entities:  

Keywords:  Arylesterase; Catalase; Ceruloplasmin; Oxidative stress; Paraoxonase; Total oxidant status

Mesh:

Substances:

Year:  2016        PMID: 27159644      PMCID: PMC6837691          DOI: 10.1080/13510002.2016.1178481

Source DB:  PubMed          Journal:  Redox Rep        ISSN: 1351-0002            Impact factor:   4.412


  29 in total

1.  A simple method for determination of serum catalase activity and revision of reference range.

Authors:  L Góth
Journal:  Clin Chim Acta       Date:  1991-02-15       Impact factor: 3.786

2.  The epidemiology of Crimean-Congo hemorrhagic fever in Turkey, 2002-2007.

Authors:  Gul Ruhsar Yilmaz; Turan Buzgan; Hasan Irmak; Ahmet Safran; Ramazan Uzun; Mustafa Aydin Cevik; Mehmet Ali Torunoglu
Journal:  Int J Infect Dis       Date:  2008-11-04       Impact factor: 3.623

3.  Proinflammatory cytokines but not acute phase serum amyloid A or C-reactive protein, downregulate paraoxonase 1 (PON1) expression by HepG2 cells.

Authors:  Yoshitaka Kumon; Yuh Nakauchi; Tadashi Suehiro; Tomoko Shiinoki; Noriyasu Tanimoto; Mari Inoue; Toshihiro Nakamura; Kozo Hashimoto; Jean D Sipe
Journal:  Amyloid       Date:  2002-09       Impact factor: 7.141

4.  Antibody responses and viral load in patients with Crimean-Congo hemorrhagic fever: a comprehensive analysis during the early stages of the infection.

Authors:  Koray Ergunay; Zeliha Kocak Tufan; Cemal Bulut; Sami Kinikli; Ali Pekcan Demiroz; Aykut Ozkul
Journal:  Diagn Microbiol Infect Dis       Date:  2014-01-07       Impact factor: 2.803

5.  A new automated colorimetric method for measuring total oxidant status.

Authors:  Ozcan Erel
Journal:  Clin Biochem       Date:  2005-10-07       Impact factor: 3.281

6.  Relationship between total thiol status and thrombocytopenia in patients with Crimean-Congo hemorrhagic fever.

Authors:  Rahmet Guner; Mehmet A Tasyaran; Siran Keske; Imran Hasanoglu; Ayse Kaya Kalem; Derya Yapar; Tugba Arslan Gulen; Salim Neselioglu; Semra Isikoglu; Ozcan Erel
Journal:  Southeast Asian J Trop Med Public Health       Date:  2012-11       Impact factor: 0.267

7.  Evaluation of the association of serum levels of hyaluronic acid, sICAM-1, sVCAM-1, and VEGF-A with mortality and prognosis in patients with Crimean-Congo hemorrhagic fever.

Authors:  Baris Ozturk; Ferit Kuscu; Ediz Tutuncu; Irfan Sencan; Yunus Gurbuz; Hakan Tuzun
Journal:  J Clin Virol       Date:  2009-12-11       Impact factor: 3.168

8.  Automated measurement of serum ferroxidase activity.

Authors:  O Erel
Journal:  Clin Chem       Date:  1998-11       Impact factor: 8.327

9.  The importance of myeloperoxidase enzyme activity in the pathogenesis of Crimean-Congo haemorrhagic fever.

Authors:  F M K Guven; H Aydin; G Yildiz; A Engin; V K Celik; D Bakir; K Deveci
Journal:  J Med Microbiol       Date:  2012-11-08       Impact factor: 2.472

10.  Evaluation of clinical and laboratory predictors of fatality in patients with Crimean-Congo haemorrhagic fever in a tertiary care hospital in Turkey.

Authors:  Cigdem Ataman Hatipoglu; Cemal Bulut; Meltem Arzu Yetkin; Gunay Tuncer Ertem; Fatma Sebnem Erdinc; Esra Kaya Kilic; Tugba Sari; Sami Kinikli; Behic Oral; Ali Pekcan Demiroz
Journal:  Scand J Infect Dis       Date:  2010-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.